Gene · 3157
Papers1,567
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 1,567
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| STAT1 signaling controls cholesterol metabolism in epithelial cells and RSV-induced syncytia formation. | Npj Viruses | 2026 | 41699197 | PubTator, text mining | PubMed |
| Aberrantly expressed long noncoding RNAs in adipose-derived mesenchymal stem cells differentiation to nucleus pulposus-like cells. | Sci Rep | 2026 | 41667574 | PubTator, text mining | PubMed |
| Time‑resolved multi-omic analysis of paclitaxel exposure in human iPSC‑derived sensory neurons unveils mechanisms of chemotherapy‑induced peripheral neuropathy. | Cell Death Dis | 2026 | 41667428 | PubTator, text mining | PubMed |
| Above-Filter Digestion Proteomics Reveals Drug Targets and Localizes Ligand Binding Site. | J Proteome Res | 2026 | 41653152 | PubTator, text mining | PubMed |
| Antigen-specific TH17 cells offset the age-related decline in durable T cell immunity. | Sci Adv | 2026 | 41650263 | PubTator, text mining | PubMed |
| Mitochondrial HMGCS1 mediates cisplatin resistance in cervical cancer through regulation of mitochondrial transcription. | BMC Mol Cell Biol | 2026 | 41545954 | PubTator, text mining | PubMed |
| Revealing differentially expressed genes between hypertrophic scars and normal skin tissues by bioinformatic analysis. | Cutan Ocul Toxicol | 2026 | 41390243 | PubTator, text mining | PubMed |
| ACLP promotes hypertrophic scar pathogenesis by enhancing myofibroblast activation and cholesterol synthesis-related gene expression. | Pathol Res Pract | 2026 | 41314002 | PubTator, text mining | PubMed |
Corrigendum to "Synergistic targeting of FASN and HMGCS1 by cerulenin enhances tumor cell ferroptosis sensitivity through rewiring lipid metabolism and blocking GPX4 biosynthesis" [Cancer Lett. (2025) 633 217992]. | Cancer Lett | 2026 | 41242917 | PubTator, text mining | PubMed |
| Excess Cholesterol Biosynthesis by Up-regulated HMGCS1 in Colorectal Cancer Cells Induced M2-like Tumor-Associated Macrophage Polarization via Extracellular Vesicles. | Cancer Res Treat | 2026 | 41084177 | PubTator, text mining | PubMed |
| The Impact of IGFBP6 Knockdown on Cholesterol Metabolism in Breast Cancer Cells. | Curr Med Chem | 2026 | 40947699 | PubTator, text mining | PubMed |
| lncRNA EBLN3P Promotes Proliferation, Metastasis and Stemness of Gastric Cancer Cells via miR-141-3p/HMGCS1. | Biochem Genet | 2026 | 40855016 | PubTator, text mining | PubMed |
| Vitamin K1 Induced Cytotoxic Effects and Transcriptomic Analysis in Jurkat T Lymphocyte Leukemia Cells. | Cancer Manag Res | 2025 | 41438502 | PubTator, text mining | PubMed |
| Fatty acid metabolism-related signature suggests an oncogenic role of FASN in cervical cancer. | Transl Cancer Res | 2025 | 41378012 | PubTator, text mining | PubMed |
| Targeting Ferroptosis in Nasopharyngeal Carcinoma: Mechanisms of Therapy Resistance and Therapeutic Opportunities. | Adv Biol (Weinh) | 2025 | 41165022 | PubTator, text mining | PubMed |
| Identification of genes related to the effects of bicalutamide and zoladex on benign prostatic hyperplasia. | Sci Rep | 2025 | 40999058 | PubTator, text mining | PubMed |
| Activity-based probes and chemical proteomics uncover the biological impact of targeting HMG-CoA Synthase 1 in the mevalonate pathway. | J Biol Chem | 2025 | 40912656 | PubTator, text mining | PubMed |
| Erratum to "RPL6 Interacts with HMGCS1 to Stabilize HIF-1α by Promoting Cholesterol Production in Hepatocellular Carcinoma". | Adv Sci (Weinh) | 2025 | 40878003 | PubTator, text mining | PubMed |
| Movement Disorder Following Hypoglycemic Encephalopathy in Mitochondrial 3-Hydroxy-3-methylglutaryl-CoA Synthase-2 (mHS) Deficiency. | Ann Intern Med Clin Cases | 2025 | 40855859 | PubTator, text mining | PubMed |
| Synergistic targeting of FASN and HMGCS1 by cerulenin enhances tumor cell ferroptosis sensitivity through rewiring lipid metabolism and blocking GPX4 biosynthesis. | Cancer Lett | 2025 | 40848803 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3157/papers?page=3